IDEXX LABORATORIES INC (IDXX) Stock Price, Forecast & Analysis

NASDAQ:IDXX • US45168D1046

635.66 USD
+4.93 (+0.78%)
At close: Feb 20, 2026
635.66 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM

IDXX Key Statistics, Chart & Performance

Key Statistics
Market Cap50.76B
Revenue(TTM)4.30B
Net Income(TTM)1.03B
Shares79.85M
Float79.30M
52 Week High769.98
52 Week Low356.14
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)13.07
PE48.64
Fwd PE42.9
Earnings (Next)04-29
IPO1991-06-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
IDXX short term performance overview.The bars show the price performance of IDXX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

IDXX long term performance overview.The bars show the price performance of IDXX in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of IDXX is 635.66 USD. In the past month the price decreased by -8.02%. In the past year, price increased by 40.39%.

IDEXX LABORATORIES INC / IDXX Daily stock chart

IDXX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX turns out to be only a medium performer in the overall market: it outperformed 68.68% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
IDXX Full Technical Analysis Report

IDXX Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IDXX. Both the health and profitability get an excellent rating, making IDXX a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IDXX Full Fundamental Analysis Report

IDXX Financial Highlights

Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 13.07. The EPS increased by 16.18% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.65%
ROA 30.34%
ROE 65.81%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%17.56%
Sales Q2Q%14.28%
EPS 1Y (TTM)16.18%
Revenue 1Y (TTM)10.42%
IDXX financials

IDXX Forecast & Estimates

22 analysts have analysed IDXX and the average price target is 781.34 USD. This implies a price increase of 22.92% is expected in the next year compared to the current price of 635.66.

For the next year, analysts expect an EPS growth of 13.36% and a revenue growth 8.92% for IDXX


Analysts
Analysts80.91
Price Target781.34 (22.92%)
EPS Next Y13.36%
Revenue Next Year8.92%
IDXX Analyst EstimatesIDXX Analyst Ratings

IDXX Ownership

Ownership
Inst Owners94.94%
Ins Owners0.21%
Short Float %2.29%
Short Ratio3.54
IDXX Ownership

IDXX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.54195.084B
ISRG INTUITIVE SURGICAL INC49.31177.398B
SYK STRYKER CORP25.15142.513B
BSX BOSTON SCIENTIFIC CORP21.29112.294B
BDX BECTON DICKINSON AND CO11.7751.988B
EW EDWARDS LIFESCIENCES CORP26.8345.797B
GEHC GE HEALTHCARE TECHNOLOGY16.7737.832B
RMD RESMED INC21.137.336B
DXCM DEXCOM INC28.9428.187B

About IDXX

Company Profile

IDXX logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE 04092 US

CEO: Jonathan J. Mazelsky

Employees: 11000

IDXX Company Website

IDXX Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IDXX FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


What is the stock price of IDEXX LABORATORIES INC today?

The current stock price of IDXX is 635.66 USD. The price increased by 0.78% in the last trading session.


What is the dividend status of IDEXX LABORATORIES INC?

IDXX does not pay a dividend.


What is the ChartMill technical and fundamental rating of IDXX stock?

IDXX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What is the analyst forecast for IDXX stock?

22 analysts have analysed IDXX and the average price target is 781.34 USD. This implies a price increase of 22.92% is expected in the next year compared to the current price of 635.66.


How is the valuation of IDEXX LABORATORIES INC (IDXX) based on its PE ratio?

The PE ratio for IDEXX LABORATORIES INC (IDXX) is 48.64. This is based on the reported non-GAAP earnings per share of 13.07 and the current share price of 635.66 USD.